Major Stocks Decline in Monday's Pre-Market Trading: Yatsen Holding, Delta Air Lines, United Airlines Among Losers

Dave Ramsey

Radio host and author promoting debt-free living through his "Baby Steps" program.

U.S. stock futures experienced a downturn on Monday morning, with the Dow futures dropping by approximately 1%. Several prominent companies, including Yatsen Holding, Delta Air Lines, and United Airlines, saw their shares fall in pre-market trading, influenced by various factors ranging from earnings reports to geopolitical events causing travel disruptions.

Yatsen Holding Ltd (NYSE:YSG) was among the steepest decliners in pre-market trading, following its fourth-quarter earnings report. The company reported adjusted earnings of 7 cents per share, a decrease from 14 cents per share in the previous year's corresponding period. Despite this, Yatsen Holding's sales observed a rise, reaching $197.258 million compared to $157.347 million year-over-year. Consequently, Yatsen's stock price declined by 10.1% to $4.00 in pre-market activities, signaling investor apprehension regarding its profitability.

The aviation sector also faced significant headwinds, with Delta Air Lines Inc (NYSE:DAL) and United Airlines Holdings Inc (NASDAQ:UAL) witnessing drops of 5.7% and 5.6%, respectively, in pre-market trading. Delta announced the suspension of its flight operations from New York’s JFK airport to Tel Aviv through March 8 and return flights through March 9. Similarly, United Airlines suspended its flights to Tel Aviv through March 6. These travel disruptions stem from escalating geopolitical tensions in the Middle East, leading to airspace closures and heightened concerns within the region.

Other companies also contributed to the overall negative sentiment in the pre-market session. Smithfield Foods Inc (NASDAQ:SFD) shares dipped by 10.1%, while Ultra Clean Holdings Inc (NASDAQ:UCTT) saw a 10% decrease following an upsized convertible senior notes offering. Honest Company Inc (NASDAQ:HNST) declined by 9.3% after reporting quarterly losses. Harrow Inc (NASDAQ:HROW) fell by 8.8% ahead of its upcoming fourth-quarter financial results. Neurogene Inc (NASDAQ:NGNE) experienced an 8.5% drop despite a recent FDA Breakthrough Therapy designation. The E W Scripps Co (NASDAQ:SSP) fell 8.4%, and Garrett Motion Inc (NASDAQ:GTX) dipped 7.7%. Rezolve AI PLC (NASDAQ:RZLV) also declined by 7.7%. Lastly, Carnival PLC (NYSE:CUK) and Norwegian Cruise Line Holdings Ltd (NYSE:NCLH) both experienced significant falls, with Carnival dropping 7.7% and Norwegian Cruise Line slipping 6.5% ahead of its quarterly earnings release. These widespread declines across various sectors indicate a cautious start to Monday's trading, reflecting a mix of company-specific news and broader market concerns.

you may like

youmaylikeicon
Market Dynamics: Teva Pharmaceutical Industries Ltd's Short Interest Analysis

Market Dynamics: Teva Pharmaceutical Industries Ltd's Short Interest Analysis

By Dave Ramsey
Big Tech's AI Investments in the Middle East Amid Regional Tensions

Big Tech's AI Investments in the Middle East Amid Regional Tensions

By Mr. Money Mustache
Broadcom Introduces VMware Telco Cloud Platform 9 for Infrastructure Cost Reduction

Broadcom Introduces VMware Telco Cloud Platform 9 for Infrastructure Cost Reduction

By T. Harv Eker
Global Markets Face Instability Amid Geopolitical Tensions and Economic Shifts

Global Markets Face Instability Amid Geopolitical Tensions and Economic Shifts

By Ramit Sethi
Immunome, Inc. Targets Billion-Dollar Market with Oncology Pipeline Advancements

Immunome, Inc. Targets Billion-Dollar Market with Oncology Pipeline Advancements

By JL Collins
Janux Therapeutics Initiates Patient Dosing for Autoimmune Drug JANX011

Janux Therapeutics Initiates Patient Dosing for Autoimmune Drug JANX011

By Ramit Sethi
Schrödinger's Strategic Shift to Licensing Fuels Significant Revenue Growth

Schrödinger's Strategic Shift to Licensing Fuels Significant Revenue Growth

By JL Collins
Cogent Biosciences Inc. (COGT) Prepares for Bezuclastinib Introduction, Awaiting FDA Approval

Cogent Biosciences Inc. (COGT) Prepares for Bezuclastinib Introduction, Awaiting FDA Approval

By Chika Uwazie
Global Markets React to Escalating Middle East Conflict: FTSE 100 Sees Decline Amidst Oil Price Surge

Global Markets React to Escalating Middle East Conflict: FTSE 100 Sees Decline Amidst Oil Price Surge

By Dave Ramsey
Berkshire Hathaway's New Era: Abel's Strategic Shift Excludes Major Holdings

Berkshire Hathaway's New Era: Abel's Strategic Shift Excludes Major Holdings

By Bola Sokunbi
EU's 'Made in Europe' Initiative: Boosting Local Battery Production and Reducing Costs

EU's 'Made in Europe' Initiative: Boosting Local Battery Production and Reducing Costs

By Scott Pape
Guardant Health Expands Precision Oncology with MetaSight Diagnostics Acquisition

Guardant Health Expands Precision Oncology with MetaSight Diagnostics Acquisition

By Bola Sokunbi
Arvinas Advances Oncology and Neurology Drug Development with Promising Trial Results

Arvinas Advances Oncology and Neurology Drug Development with Promising Trial Results

By Chika Uwazie
Supermicro's Strategic Leap into AI-RAN for Telecom Sector Growth

Supermicro's Strategic Leap into AI-RAN for Telecom Sector Growth

By Natalie Pace
EU's 'Made in Europe' Initiative Aims to Significantly Reduce Battery Costs

EU's 'Made in Europe' Initiative Aims to Significantly Reduce Battery Costs

By JL Collins